Latest Breaking News On - Softbank fund - Page 4 : comparemela.com

LUMICKS Raises $93 Million in Series D Financing - Backed by global investor syndicate led by new investors Farallon Capital Management and Lauxera Capital Partners along with Softbank Fund 2, funds and accounts advised by T. Rowe Price Associates, Parian Global Management, Gilde Healthcare, Pura Vida Investments, and Irving Investors AMSTERDAM, April 16, 2021 /PRNewswire/ LUMICKS, a leading, next-generation life science tools company that develops highly innovative platforms for Dynamic Single-Molecule and Cell Avidity analysis, announced the completion of a $93 million Series D preferred share financing. The funding round was led by new investors Farallon Capital Management and Lauxera Capital Partners, and included investments by Softbank Vision 2

France generalSan franciscoUnited statesNoord hollandKostenloser wertpapierhandelErwin petermanIddo hellerOlivier heyningKassandra barbetseaGijs wuiteWilliam blairSoftbank vision fundSoftbank fundSoftbank group corpT rowe price associatesFarallon capital management